Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pace links up with V-Tech to offer cardiac test panel

This article was originally published in Clinica

Executive Summary

Pace, a Canadian developer of diagnostic tests, has signed an exclusive OEM deal with V-Tech of El Monte, California, for the manufacture of rapid, quantitative tests to detect cardiac markers, including Pace's glycogen phosphorylase BB marker (GPBB). Under the agreement, Pace will pay $400,000 to develop GPBB tests jointly with V-Tech. In return, Pace will receive exclusive rights to the use of V-Tech's technology in testing for GPBB and non-exclusive rights to market and sell CK-MB and myoglobin tests, using similar technology.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT088429

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel